Economic Evaluation

Uses

Comparisons

Evidence quality

Highlighted claims

• The review includes five established economic evaluation types. — Cost-effectiveness of infection prevention and control measures for carbapenem-resistant Gram-negative bacilli: A systematic review protocol
• The review extracts outcomes including net cost savings, ICERs, cost per QALY, cost per DALY, and incremental benefit-cost ratios. — Cost-effectiveness of infection prevention and control measures for carbapenem-resistant Gram-negative bacilli: A systematic review protocol
• Cost-minimisation analysis asks which intervention achieves equivalent outcomes at the lowest cost. — Cost-effectiveness of infection prevention and control measures for carbapenem-resistant Gram-negative bacilli: A systematic review protocol
• Cost-effectiveness analysis asks what the cost is per unit of health gained. — Cost-effectiveness of infection prevention and control measures for carbapenem-resistant Gram-negative bacilli: A systematic review protocol
• Cost-utility analysis evaluates cost per quality-adjusted life-year gained. — Cost-effectiveness of infection prevention and control measures for carbapenem-resistant Gram-negative bacilli: A systematic review protocol
• Studies that report only clinical outcomes without economic analysis are excluded. — Cost-effectiveness of infection prevention and control measures for carbapenem-resistant Gram-negative bacilli: A systematic review protocol